价格

Exon 53

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
EP 3554552 A1申请人: SAREPTA THERAPEUTICS INC优先权: 2016
CN
EP
US
WO
9 件公开
METHODS AND MEANS FOR EFFICIENT SKIPPING OF AT LEAST ONE OF THE FOLLOWING EXONS OF THE HUMAN DUCHENNE MUSCULAR DYSTROPHY GENE: 43, 46, 50-53
US 2011263682 A1申请人: ACADEMISCH ZIEKENHUIS LEIDEN优先权: 2007
CN
EP
US
6 件公开
Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure
US 10113165 B2申请人: ACADEMISCH ZIEKENHUIS LEIDEN优先权: 2014
US
5 件公开
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
EP 3495485 A3申请人: SAREPTA THERAPEUTICS INC优先权: 2013
CN
EP
US
4 件公开
EXON SKIPPING OLIGOMERS AND OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
- EP 3784248 A2
  申请人: SAREPTA THERAPEUTICS INC优先权: 2018
  EP
  US
  WO
  4 件公开
- US 20250090569 A1
  申请人: SAREPTA THERAPEUTICS INC优先权: 2024
  US
Effective gene therapy tools for dystrophin exon 53 skipping
US 10752898 B2申请人: GENETHON优先权: 2015
CN
EP
US
3 件公开
OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
EP 3790596 A1申请人: WAVE LIFE SCIENCES LTD优先权: 2018
CN
EP
WO
3 件公开
PRECISE EXCISIONS OF PORTIONS OF EXON 44, 50, AND 53 FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
EP 4490292 A1申请人: VERTEX PHARMA优先权: 2022
EP
US
WO
3 件公开
IMPROVED EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
EP 3885439 A1申请人: SAREPTA THERAPEUTICS INC优先权: 2012
CN
EP
3 件公开
Medicament for treatment of Duchenne muscular dystrophy
US 6653467 B1申请人: JCR PHARMACEUTICAL CO LTD优先权: 2000
US

药物

Exon 53

专利

EXON SKIPPING OLIGOMERS AND OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY